Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Appointed director
CC transcript
Inv. presentation
Director departure
|
|
INTERPACE BIOSCIENCES, INC. (IDXG)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/01/2022 |
SC 13D/A
| Kamin Peter reports a 18.6% stake in Interpace Biosciences, Inc. |
| 01/13/2022 |
SC 13D/A
| Kamin Peter reports a 18.6% stake in Interpace Biosciences, Inc. |
| 12/06/2021 |
SC 13D/A
| Kamin Peter reports a 18.7% stake in Interpace Biosciences, Inc. |
| 11/12/2021 |
SC 13D/A
| 1315 Capital II, L.P. reports a 26.4% stake in INTERPACE BIOSCIENCES, INC. |
| 11/12/2021 |
SC 13D/A
| Ampersand 2018 Limited Partnership reports a 38.9% stake in INTERPACE BIOSCIENCES, INC. |
| 05/19/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/18/2021 |
SC 13D/A
| Ampersand 2018 Limited Partnership reports a 39.1% stake in INTERPACE BIOSCIENCES, INC. |
| 01/21/2021 |
SC 13D/A
| 1315 Capital II, L.P. reports a 26.6% stake in INTERPACE BIOSCIENCES, INC. |
| 01/19/2021 |
SC 13D/A
| Ampersand 2018 Limited Partnership reports a 39.3% stake in INTERPACE BIOSCIENCES, INC. |
| 08/20/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/30/2020 |
SC 13D/A
| 1315 Capital II, L.P. reports a 26.7% stake in INTERPACE BIOSCIENCES, INC. |
| 01/17/2020 |
SC 13D/A
| Ampersand 2018 Limited Partnership reports a 39.4% stake in INTERPACE BIOSCIENCES, INC. |
| 04/26/2016 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 04/06/2016 |
SC 13D/A
| Interpace Diagnostics Group, Inc. reports a 16.5% stake in Interpace Diagnostics Group, Inc. |
|
|